← Evidence map

ArticleInfection2024

In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National Registry.

Silvano Esposito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38324144